With efforts to find alternative treatments for chronic diseases like leukemia, HIV and SCID, gene therapy proves to be a groundbreaking discovery, says RNCOS in its latest research report.
Noida, UP -- (SBWIRE) -- 10/24/2014 -- According to a new research report by RNCOS entitled, “Global Gene Therapy Market Outlook 2018”, new innovations in the field of healthcare industry are driven by groundbreaking gene therapy trials against cancer, HIV, retinal disorder, SCID, etc. The field has emerged as an area of immense potential and has witnessed increasing research and developments during the past few years. The industry is driven by the failure of conventional therapies to treat life-threatening diseases, which is opening doors for biotech companies to find alternative ways of treating diseases. Other therapeutic areas such as cardiovascular disease, ophthalmology, genetic and neurological disorders are also being targeted by companies.
Moreover, to advance research in gene therapy, various venture capital firms are showing their interest in terms of series A and B financing. As per the new estimation carried out in our latest study, the global gene therapy market is anticipated to attain an exceptional growth with the advent of new drugs, like in the US and the European markets. However, it will take 4-6 years more for the market to attain an optimum level of success.
Research Analysis and Highlights
The report is spread in over 120 pages and provides an in-depth research and rational analysis of the global gene therapy market. A brief overview of the key geographies in the gene therapy segment and the regulatory scenario governing the industry has also been included in the study to present a balanced outlook. The report covers how major trends and drivers, including nanotechnology, advanced therapies to treat chronic diseases etc., will propel the industry’s growth. With a view to understand the competitive landscape, the profiles of key market players are included in the report to present a complete picture of the global gene therapy market.
Some of the report’s key highlights include:
- Mergers and Acquisitions advancing gene therapy research and development
- US showing dynamic research and development for gene therapy
- Growing clinical trials for gene therapy worldwide
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM715.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.